Drug Concentrations, Immunogenicity Predict Anti-TNF Treatment Failure Drug Concentrations, Immunogenicity Predict Anti-TNF Treatment Failure

About one-quarter of patients with active luminal Crohn ' s disease (CD) do not respond to anti-tumor necrosis factor (TNF) drugs, while about two-thirds don ' t achieve remission, according to new research.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news